Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fiducian Group Ltd ( (AU:FID) ) has provided an update.
Fiducian Group Limited has responded to an ASX price query, stating it is not aware of any undisclosed information that could explain recent trading in its securities, despite an APRA announcement imposing additional licence conditions on its superannuation fund trustee. The company maintains that these APRA conditions relate only to a regulated subsidiary, do not affect the ongoing operations or safety of members’ assets, have no material impact on future earnings, and confirms full compliance with ASX continuous disclosure rules.
The trustee of the Fiducian Superannuation Fund has acknowledged APRA’s oversight, pledged constructive engagement, and committed to appointing independent experts to review governance, investment options and board operations, while stressing that high-risk products have been avoided. Fiducian also confirms its responses to the ASX have been authorised under its continuous disclosure policy, seeking to reassure investors and regulators that its regulatory issues are contained and operationally manageable.
The most recent analyst rating on (AU:FID) stock is a Hold with a A$10.50 price target. To see the full list of analyst forecasts on Fiducian Group Ltd stock, see the AU:FID Stock Forecast page.
More about Fiducian Group Ltd
Fiducian Group Limited is an Australian financial services company operating in wealth management and superannuation. Through its Fiducian Superannuation Fund, the group offers retirement savings products and related investment options to members, operating under an APRA-regulated structure within the domestic financial services market.
Average Trading Volume: 22,533
Technical Sentiment Signal: Hold
Current Market Cap: A$302.4M
See more data about FID stock on TipRanks’ Stock Analysis page.

